We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Try the New Site
We're building a modernized ClinicalTrials.gov! Visit Beta.ClinicalTrials.gov to try the new functionality.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04071223
Brief Title: Testing the Addition of a New Anti-cancer Drug, Radium-223 Dichloride, to the Usual Treatment (Cabozantinib) for Advanced Renal Cell Cancer That Has Spread to the Bone, the RadiCaL Study
First Submitted : August 26, 2019
First Submitted that Met QC Criteria : August 26, 2019
First Posted : August 28, 2019
Last Update Submitted that Met QC Criteria : May 24, 2023
Last Update Posted : May 25, 2023